Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.

by Tetsuro Miyazaki, Stephanie Chiuve, Frank M Sacks, Paul M Ridker, Peter Libby, Masanori Aikawa
Published 2014-01-01